摘要
目的 观察干扰素γ在人肺癌A549细胞放射治疗中的作用,探讨肺癌治疗的新途径.方法 单独γ射线辐照细胞或联合应用干扰素γ处理细胞,采用MTT法检测细胞存活率,Western印迹法分析细胞P53蛋白表达的变化,流式细胞仪测定细胞周期的变化.结果 与单独γ射线(5 Gy)作用相比,干扰素γ( 1.0 U/ml)和γ射线联合应用能明显降低A549细胞的存活率(71.4%±2.1%比44.1%±3.1%,n=7,P<0.01);此外,与对照组相比,单独γ射线辐照组和单独干扰素γ给药组A549细胞P53蛋白表达水平有所升高(P<0.05),而干扰素γ和γ射线联合作用组细胞P53蛋白表达水平明显高于对照组(P<0.01);同时与单独γ射线治疗相比,联合治疗还能够显著影响细胞周期的变化,S期细胞增加(12.9%比20.9%,n=5,P< 0.05),并引起G2/M期细胞阻滞(28.8%比38.9%,n=5,P< 0.05).结论 干扰素γ和γ射线联合应用可以提高人肺癌A549细胞的放射治疗效果,在肺癌的治疗中可能具有一定的应用价值.
Objective To define the role of interferon-γon radiotherapy of lung cancer and explore a new way to clinical treatment.Methods A549 cells were exposed toγray with or without IFN-γ cotreatment.MTT assay was performed to evaluate cell viability. Western blot was used to observe the expression of P53 protein.Results The results showed that co-treatment of IFN-γ decreased the cell viability significantly compared with the γ ray irradiation group(71.4% ±2.1% vs 44.1% ±3.1%,n =7,P 〈 0.01 ).In addition,the expression of P53 protein also increased significantly after co-treatment (P 〈0.01) ; Furthermore,the cell cycle was changed obviously in co-treatment group compared with γ ray irradiation group,S phase increased ( 12.9% vs 20.9%,n =5,P 〈 0.05 ) and also blocked the G2/M phase (28.8% vs 38.9%,n=5,P〈 0.05).Conclusions The results suggested that γray irradiation combined with IFN-γ can increase the efficiency of radiotherapy on A549 cells and there is much broad prospect in the clinical treatment of lung cancer.
出处
《中华医学杂志》
CAS
CSCD
北大核心
2012年第5期348-350,共3页
National Medical Journal of China